Syngene International Ltd (SYNGENE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 197397, "name": "Syngene Intl.", "stock_name": "Syngene Intl.", "full_name": "Syngene International Ltd", "name_url": "stocks-analysis/syngene-intl", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "450.10", "chg": -1.3, "chgp": "-0.29%", "dir": -1, "prev_price": "451.40", "mcapval": "17,866.00 Cr", "mcap": "Small Cap", "scripcode": 539268, "symbol": "SYNGENE", "ind_name": "Healthcare Services", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE398R01022", "curr_date": "May 06", "curr_time": "", "bse_nse_vol": "27.31 lacs", "exc_status": "Active", "traded_date": "May 06, 2026", "traded_date_str": "2026 05 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syngene-intl-197397-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Syngene International Ltd Gains 11.09%: 5 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-gains-1109-5-key-factors-driving-the-weeks-rally-3971937", "imagepath": "", "date": "2026-05-03 14:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Apr:</strong> Stock opens strong at Rs.437.90 (+3.96%) amid broad market gains</p>\n <p><strong>28 Apr:</strong> Modest price rise to Rs.440.00 (+0.48%) despite Sensex dip</p>\n <p><strong>29 Apr:</strong> Price retreats to Rs.432.05 (-1.81%) on low volume</p>\n <p><strong>30 Apr:</strong> Syngene surges to upper circuit at Rs.491.40 (+16.62%) on record volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.421.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week C..." }, { "title": "Are Syngene International Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-syngene-international-ltd-latest-results-good-or-bad-3970715", "imagepath": "", "date": "2026-04-30 19:14:25", "description": "Syngene International Ltd's latest financial results for Q4 FY26 present a nuanced picture of the company's performance. The Bengaluru-based contract research organization reported net sales of ₹1,036.50 crores, marking the highest quarterly revenue in its recent history, with a quarter-on-quarter growth of 13.02%. This sequential recovery indicates improved business momentum, likely driven by project ramp-ups and enhanced capacity utilization across its integrated research and manufacturing facilities. However, year-on-year revenue growth was modest at 1.82%, reflecting challenges in sustaining robust top-line expansion.\n\nOn the profitability front, net profit for the quarter reached ₹147.90 crores, which represents a significant quarter-on-quarter growth of 886.00%. Nevertheless, this figure reflects a year-on-year decline of 19.31%, raising concerns about the sustainability of profitability. The operatin..." }, { "title": "Syngene International Ltd Locks at Upper Circuit With 16.6% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3970299", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_stocks_hitting_upper_circuit_3970299.png", "date": "2026-04-30 14:00:05", "description": "At Rs 518.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Syngene International Ltd locked at its upper circuit of 20% on 30 Apr 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Syngene International Ltd Sees Robust Trading Activity Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-sees-robust-trading-activity-amid-mixed-technical-signals-3969832", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_most_active_equities_by_value_3969832.png", "date": "2026-04-30 10:00:09", "description": "Syngene International Ltd, a prominent player in the Healthcare Services sector, witnessed a significant spike in trading value on 30 April 2026, emerging as one of the most actively traded stocks by value. Despite a strong intraday rally and outperformance against its sector, the stock remains under a cautious rating outlook, reflecting a complex interplay of market enthusiasm and fundamental concerns." }, { "title": "Syngene International Ltd Sees Exceptional Volume Surge Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-sees-exceptional-volume-surge-amid-mixed-technical-signals-3969820", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_most_active_equities_by_volume_3969820.png", "date": "2026-04-30 10:00:05", "description": "Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 30 Apr 2026, with over 75 lakh shares exchanging hands. This volume spike accompanied a robust price rally, as the stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its Mojo Grade." }, { "title": "Syngene International Q4 FY26: Profit Surge Masks Underlying Margin Pressures", "link": "https://www.marketsmojo.com/news/result-analysis/syngene-international-q4-fy26-profit-surge-masks-underlying-margin-pressures-3970176", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_quaterlyResult_3970176.png", "date": "2026-04-30 09:45:43", "description": "Syngene International Ltd., the integrated contract research and manufacturing services provider, reported a dramatic rebound in quarterly net profit for Q4 FY26, posting ₹147.90 crores—a staggering 886.00% surge quarter-on-quarter from the anaemic ₹15.00 crores in Q3 FY26. However, this impressive sequential recovery masks a more sobering reality: profits declined 19.31% year-on-year from ₹183.30 crores in Q4 FY25, whilst the stock rallied 7.68% to ₹465.25 following the results announcement, reflecting investor relief at the sequential improvement despite persistent underlying challenges." }, { "title": "Syngene International Ltd Surges 10.18% to Day's High of Rs 477.55 — Outperforms Sector by 9.33 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-hits-intraday-high-with-1018-surge-on-30-april-2026-3969698", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_priceRelatedfactors_3969698.png", "date": "2026-04-30 09:30:47", "description": "While the Sensex declined by 1.22% on 30 Apr 2026, Syngene International Ltd surged 10.18%, touching an intraday high of Rs 477.55. This 9.33-percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a broadly weak market environment." }, { "title": "Syngene International Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-ltd-is-rated-sell-3966322", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyngeneInternat_mojoScore_3966322.png", "date": "2026-04-28 10:10:55", "description": "Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company's outlook." }, { "title": "Syngene International Gains 7.65%: Technical Shift and Financial Challenges Shape Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-gains-765-technical-shift-and-financial-challenges-shape-week-3953146", "imagepath": "", "date": "2026-04-19 14:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock opens at Rs.402.95, down 0.44% amid broader market weakness</p>\n <p><strong>15 Apr:</strong> Strong rebound with 2.56% gain to Rs.413.25 on heavy volume</p>\n <p><strong>16 Apr:</strong> Technical upgrade announced; stock surges 5.19% to Rs.434.70</p>\n <p><strong>17 Apr:</strong> Rating upgraded to Sell; stock closes at Rs.435.70, up 0.23%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.404.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." } ], "total": 330, "sid": "197397", "stock_news_url": "https://www.marketsmojo.com/news/syngene-international-197397" }, "announcements": [ { "details": "Syngene International Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "09-Dec-2019" }, { "details": "Syngene International Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "27-Nov-2019" }, { "details": "Syngene International Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "26-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 25 Jun 26", "dt": "2026-06-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19", "dt": "2019-06-11", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

27 Apr: Stock opens strong at Rs.437.90 (+3.96%) amid broad market gains

28 Apr: Modest price rise to Rs.440.00 (+0.48%) despite Sensex dip

29 Apr: Price retreats to Rs.432.05 (-1.81%) on low volume

30 Apr: Syngene surges to upper circuit at Rs.491.40 (+16.62%) on record volume

Week Open

Rs.421.20

Week C...

Read full news article

Are Syngene International Ltd latest results good or bad?

2026-04-30 19:14:25

Syngene International Ltd's latest financial results for Q4 FY26 present a nuanced picture of the company's performance. The Bengaluru-based contract research organization reported net sales of ₹1,036.50 crores, marking the highest quarterly revenue in its recent history, with a quarter-on-quarter growth of 13.02%. This sequential recovery indicates improved business momentum, likely driven by project ramp-ups and enhanced capacity utilization across its integrated research and manufacturing facilities. However, year-on-year revenue growth was modest at 1.82%, reflecting challenges in sustaining robust top-line expansion. On the profitability front, net profit for the quarter reached ₹147.90 crores, which represents a significant quarter-on-quarter growth of 886.00%. Nevertheless, this figure reflects a year-on-year decline of 19.31%, raising concerns about the sustainability of profitability. The operatin...

Read full news article

Syngene International Ltd Locks at Upper Circuit With 16.6% Gain — Buyers Queue, Sellers Absent

2026-04-30 14:00:05

At Rs 518.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Syngene International Ltd locked at its upper circuit of 20% on 30 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Syngene International Ltd Sees Robust Trading Activity Amid Mixed Technical Signals

2026-04-30 10:00:09

Syngene International Ltd, a prominent player in the Healthcare Services sector, witnessed a significant spike in trading value on 30 April 2026, emerging as one of the most actively traded stocks by value. Despite a strong intraday rally and outperformance against its sector, the stock remains under a cautious rating outlook, reflecting a complex interplay of market enthusiasm and fundamental concerns.

Read full news article

Syngene International Ltd Sees Exceptional Volume Surge Amid Mixed Technical Signals

2026-04-30 10:00:05

Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 30 Apr 2026, with over 75 lakh shares exchanging hands. This volume spike accompanied a robust price rally, as the stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its Mojo Grade.

Read full news article

Syngene International Q4 FY26: Profit Surge Masks Underlying Margin Pressures

2026-04-30 09:45:43

Syngene International Ltd., the integrated contract research and manufacturing services provider, reported a dramatic rebound in quarterly net profit for Q4 FY26, posting ₹147.90 crores—a staggering 886.00% surge quarter-on-quarter from the anaemic ₹15.00 crores in Q3 FY26. However, this impressive sequential recovery masks a more sobering reality: profits declined 19.31% year-on-year from ₹183.30 crores in Q4 FY25, whilst the stock rallied 7.68% to ₹465.25 following the results announcement, reflecting investor relief at the sequential improvement despite persistent underlying challenges.

Read full news article

Syngene International Ltd Surges 10.18% to Day's High of Rs 477.55 — Outperforms Sector by 9.33 Percentage Points

2026-04-30 09:30:47

While the Sensex declined by 1.22% on 30 Apr 2026, Syngene International Ltd surged 10.18%, touching an intraday high of Rs 477.55. This 9.33-percentage-point outperformance over its Healthcare Services sector peers highlights a distinctly stock-specific rally amid a broadly weak market environment.

Read full news article

Syngene International Ltd is Rated Sell

2026-04-28 10:10:55

Syngene International Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent and relevant data to assess the company's outlook.